Medical management of glaucoma: Principles and practice.

Simple item page
dc.contributor.authorSingh, Kuldev
dc.contributor.authorShrivastava, Anurag
dc.date.accessioned2012-01-03T08:05:08Z
dc.date.available2012-01-03T08:05:08Z
dc.date.issued2011-01
dc.description.abstractGlaucoma care is more an art than science. The introduction of several new classes of glaucoma medications and the completion of many large randomized clinical trials have not changed this fact. While we now have better choices when initiating glaucoma therapy relative to our predecessors, the principles of glaucoma therapy have not changed much during this period. Debates continue regarding the utility of concepts such as “the monocular therapeutic trial,” “target intraocular pressure (IOP),” and “maximal medical therapy.” Our tools for detecting and following glaucomatous disease have improved but are not precise enough for us to prospectively predict which patients will do better or worse than others. Much attention has been given to disease stage, rate of progression, and compliance with medications but regular patient follow-up, an area that has received little attention, may be among the most important predictors of patient outcomes.en_US
dc.identifier.citationSingh Kuldev, Shrivastava Anurag. Medical management of glaucoma: Principles and practice. Indian Journal of Ophthalmology. 2011 Jan; 59 (Suppl1): 88-92.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/136257
dc.language.isoenen_US
dc.source.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038497/en_US
dc.subjectGlaucomaen_US
dc.subjectmaximal medical therapyen_US
dc.subjectmedical managementen_US
dc.subjecttarget intraocular pressureen_US
dc.subject.meshAdrenergic alpha-Antagonists --therapeutic use
dc.subject.meshAdrenergic beta-Antagonists --adverse effects
dc.subject.meshAdrenergic beta-Antagonists --therapeutic use
dc.subject.meshAntihypertensive Agents --therapeutic use
dc.subject.meshCarbonic Anhydrase Inhibitors --therapeutic use
dc.subject.meshDisease Progression
dc.subject.meshFollow-Up Studies
dc.subject.meshGlaucoma --drug therapy
dc.subject.meshGlaucoma --physiopathology
dc.subject.meshGoals
dc.subject.meshHumans
dc.subject.meshIntraocular Pressure --drug effects
dc.subject.meshParasympathomimetics --therapeutic use
dc.subject.meshProstaglandins --adverse effects
dc.subject.meshProstaglandins --therapeutic use
dc.titleMedical management of glaucoma: Principles and practice.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijo2011v59(Suppl)n1p88.pdf
Size:
489.53 KB
Format:
Adobe Portable Document Format
Description:
Journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Indian Journal of Ophthalmology